SLC5A2 and diabetic kidney disease: Currently, the commonly used clinical drugs for treating DKD include renin-angiotensin system (RAS) inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and aldosterone receptor antagonists.